264620 Systems-level evaluation of large-scale, combination HIV prevention programs in 12 high prevalence MSAs

Tuesday, October 30, 2012 : 9:00 AM - 9:15 AM

Holly Fisher, PhD , Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA
Tamika Hoyte, MPH , Division of HIV AIDS, Centers for Disease Control and Prevention, Atlanta, GA
Kimberly Nguyen, MS, MPH , Office on Smoking and Health, Centers for Disease Control and Prevention (CDC), Atlanta, GA
Issue: The U.S. HIV/AIDS epidemic is concentrated in 12 metropolitan statistical areas (MSAs) representing 44% of all AIDS cases. To reduce risk of HIV transmission/infection in these communities, an integrated, evidence-based approach that includes an optimal mix of biomedical, behavioral, and structural interventions is needed.

Description: CDC's Enhanced Comprehensive HIV Prevention Planning (ECHPP) project supports combination HIV prevention, care, and treatment programs and the National HIV/AIDS Strategy in 12 MSAs. The ECHPP evaluation comprises a systems-level, population-based approach whereby key process, outcome, and impact indicators are tracked (2008 to 2015) to assess program success at the individual, community, and structural levels. Local, contextual factors (e.g., homelessness, poverty rates) that may also affect program results are monitored. The overarching purpose of this new evaluation strategy is to determine whether scaled-up, HIV prevention/care/treatment programs are working in the highest prevalence areas.

Lessons learned: Challenges and successes related to indicator development, differences in cross-jurisdiction reporting capacity, the integration and triangulation of data from multiple and varied sources, local/state/federal stakeholder negotiations, and differences in reporting cycles across data sources will be described.

Recommendations: Effective monitoring and evaluation of scaled, combination prevention programs requires: 1) identification of indicators that are both informative and feasible, 2) cross-jurisdiction standardization of indicator reporting where possible, 3) synthesis and integration of data from multiple, diverse data sources using multiple data collection methods, 4) close coordination with stakeholders at multiple levels, and 5) a flexible evaluation approach that adapts to real-world programs that may evolve over time.

Learning Areas:
Conduct evaluation related to programs, research, and other areas of practice

Learning Objectives:
Describe a systems-level, population-based evaluation approach that is appropriate for evaluation of the scale-up of public health programs in major metropolitan areas. List key factors to consider when evaluating combination prevention programs where a variety of biomedical, behavioral, and structural-level interventions are implemented in a given geographic area.

Keywords: Evaluation, HIV/AIDS

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have a PHD and am a senior behavioral scientist at CDC. I have been lead author on numerous peer-reviewed journal articles and national conference presentations. I routinely (each year) co-author journal articles and make conference presentations on program evaluation projects in HIV prevention. Additionally, I am the evaluation lead on the project described in the abstract and lead all activities related to monitoring and evaluation of the program.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.